chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got the dose and left the pharmacy with his girlfriend. Few minutes later, girlfriend came back and stated that the patient just blacked out in the car and had a seizure-like episode.  I asked him to have a seat and called for emergency medical services. They took his vitals and he seemed to be okay.
Information has been received concerning a male in his 50's with a history of colon cancer who was vaccinated with ZOSTAVAX.  Subsequently "7-8 days after receiving ZOSTAVAX," the patient developed shingles.  The patient sought unspecified medical attention.  The patient's shingles persisted.  Additional information has been requested.
1.  On 4/21/2021 at approximately 3:00 p.m., Patient experienced severe pain in his right side under his rib cage, followed by vomiting. The next bowel movement was abnormal in color (white). He has been experiencing pain day and night until last night when the pain subsided. 2. Pain in foot - He started having pain in his right foot on 4/21/2021 in the evening. The pain has become progressively worse as days go by. Last night 4/24/2021 the foot started to show pink color in the lower half of the foot. This morning, the foot showed swelling and pink on the top of the foot.  By the end of the day the foot pain is so severe he can hardly walk on it. 3. Blood in urine - He started having blood showing up in his urine on 4/21/2021 in the evening.
Pt exp fever&lt side body swelled following vax;1st&2nd dose given FEB90&MAR90 respectively;SX occurred less than 24 hrs /p vax&resolved; reporter indicated p/2nd vax pt exp tingling&swelling of lt arm fr shoulder to fingertips 2 hrs /p vax
Pt given outside of FDA approved age limits.  Pt is 9 and youngest limit is 11.  No reported adverse reaction or illness reported by patient or family.  Pt required tetanus due to dirty wound and more than 5 years since last tetanus dose.
by 4:45 pm I felt off. By 6:30 pm I felt like I couldn't move very well. It affected all the bones I have ever broken or sprained before. Had cold chills, my temperature was 95.1. I felt like my blood pressure was high. I had a bad headache and took advil. April 11th I still felt off and had a headache. Around 4:30 pm I had rectal bleeding. Wednesday April 14th I had very bad leg pain in my right leg. Friday April 16th I went to urgent care for Leg pain and slight chest pain. They sent me to the ER. I had a chest Xray and ekg done and both came back normal. I was able to have a vascular ultrasound Monday April 19th in right leg and it showed no blood clots. I still have leg pain April 22nd.
States had headache last night and was experienced hoarseness this am. After talking pt changed her mind and states her symptoms started last evening. Lungs CTA, bp 120/90, eyes watery.
Post- vaccine menorrhagia. Bleeding through a tampon every hour for 5 hrs., then every 3 hrs. for 24 hours. Heavy abdominal cramping, lightheaded-ness, and weakness when standing.
I only had mild symptoms after the 1st dose, sore arm, and fatigue; I only had mild symptoms after the 1st dose, sore arm, and fatigue; This is a spontaneous report from a contactable female consumer (patient herself) via Pfizer-sponsored program. A 55-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: WAG09, expiry date: unknown) via unspecified route of administration, in right arm (or right shoulder at the top of arm as reported) on 20Jul2021 11:40 (age at vaccination: 54-years) as dose 1, single for covid-19 immunisation. Vaccine was not administered at military facility. Medical history of patient included ongoing high blood pressure. Co-suspect drug included ongoing amlodipine 5 mg, daily, taken for unspecified indication, start and stop date unknown. She had no family medical history relevant to ae. On 20Jul2021, patient experienced only mild symptoms after the 1st dose, sore arm, and fatigue. Patient stated she didnt have much fatigue. The fatigue lasted about a day, didnt last very long, about 24 hours. Patient had not received the second dose Pfizer Covid 19 Vaccine yet, and was planning to receive the second dose tomorrow, 12Aug2021. No other vaccines was administered on same date with the Pfizer vaccine considered as suspect. There was no physician office or emergency room visit due to the adverse events. There were no prior vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. Patient previously took the tetanus shot that was years ago, over 10 years ago. No relevant tests were done due to the adverse events. The outcome of the events was recovered on 21Jul2021.   Follow-Up (18Aug2021): Follow-up attempts are completed. No further information is expected.
pretty affected by the first two doses/it was very hard; felt weak; arm was weak; chills; headache for almost a month; fatigue; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak), MUSCULAR WEAKNESS (arm was weak), CHILLS (chills) and HEADACHE (headache for almost a month) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE and HYDROXYZINE EMBONATE (HYDROXYZINE PAMOATE) for an unknown indication.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak), MUSCULAR WEAKNESS (arm was weak), CHILLS (chills), HEADACHE (headache for almost a month), FATIGUE (fatigue) and MYALGIA (soreness). At the time of the report, VACCINATION COMPLICATION (pretty affected by the first two doses/it was very hard), ASTHENIA (felt weak) and MUSCULAR WEAKNESS (arm was weak) outcome was unknown and CHILLS (chills), HEADACHE (headache for almost a month), FATIGUE (fatigue) and MYALGIA (soreness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-342395 (Patient Link).
Child c/o joint pain through out the day. On 2/21/13, developed a rash on ankles on 2/22/13, swelling of joints and worsening of rash on 2/23/13, all over body rash and lower extremety joint pain/swelling on 2/24/13-2/27/13.
Mom verbalizes client started with a fever on 01/11/02 then developed a rash on 01/12/02 but no fever. Client developed a generalized rash to stomach and back a couple of spots on face, arm pits and a spot on the right side of the forehead and a spot to the right leg. (Fever on 01/11/2002 was 101 degrees F.) Rashes gone on 01/16/2002.
Myalgia, Fever, NauseaVomiting, Fatigue Narrative:  Covid Team nurse reported patient called last Friday and missed work that day. Reported fatigue, fever, nausea and body aches.
This spontaneous prospective pregnancy report as received from a nurse refers to a 25 years old female patient for VARIVAX (Merck), a Pregnancy Registry product, concerning vaccine exposure during pregnancy. The patient was "5 and 1/2 weeks pregnant as of 31-OCT-2012". The patient's history of previous pregnancies and live births is not known. It has been reported that the patient has no pertinent medical history and no drug reactions or allergies. The patient was vaccinated with VARIVAX (Merck) (dose and route not reported, lot number H006950, exp. date 16-MAR-2014) on 23-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. Subsequently, the patient became pregnant with an estimated Last menstrual period (LMP) of 22-SEP-2012 and an Estimated Date of Delivery (EDD) of 30-JUN-13. Initial exposure to VARIVAX (Merck) was estimated at 5 week(s). The patient was exposed to VARIVAX (Merck) during trimester 1. On 23-OCT-2012 the patient received VARIVAX (Merck) while pregnant. The patient experienced no adverse event. No treatment information was reported. The outcome of received VARIVAX (Merck) while pregnant was unknown. The relatedness for VARIVAX (Merck) while pregnant and no adverse event was unknown. It has been reported that the patient saw a nurse in regards to the events. This follow-up was received from a Register Nurse who reported the patient had a miscarriage in an approximately December 2012 followed by a D&C (Dilation and Curettage) procedure on 28-DEC-2012. The reporter stated that there were ultrasound, genetic tests and home pregnancy test performed (no results and dates provided). The outcome and relatedness for VARIVAX (Merck) regarding to the patient's events were not reported. Upon internal review, the patient's event of miscarriage was considered to be an other important medical event. Additional information is not expected. 15-JUL-2013. This is a correction. The 'as reported causality' for the event of drug exposure during pregnancy was updated to 'not related'.
Severe site bruising (black/blue/purple) (bleeding under the skin - per Dr.).
1st dose given subcutaneously; This case was reported by a consumer via call center representative and described the occurrence of intramuscular formulation administered by other route in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd October 2021, the patient received the 1st dose of Shingrix (subcutaneous). On 22nd October 2021, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were provided as follows: The patient received his first dose of Shingrix and it was given subcutaneously, which led to intramuscular formulation administered by other route. The reporter did not consent to follow-up.
Child received a 2nd dose of FluMist and should have only received one dose, due to age. No treatment. Spoke with child's mother , who stated child had a fever (parent did not know what temperature was), vomiting, stomach ache, and headache. She stated the symptoms resolved with in 4 -5 days. No other symptoms noted. Adverse event reported to the Department of Health.
administration of Infanrix to an adult patient about "2 months ago".; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a adult male patient who received DTPa (Infanrix) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   In May 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. In May 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. About 2 months ago from the date of reporting, the adult patient received Infanrix which led to inappropriate age at vaccine administration. Reporter stated that, the patient was doing fine. Reporter did not have any additional demographic details about the patient. The reporter consented to follow up.
High fever; Severe sinus pain, Severe pain in neck, shoulders hands and feet; Symptoms lasted for 3 days; Fever controlled with tylenol
Developed symptoms by 3pm, flu like symptom, headache, myalgias, by Wednesday started vesicular rash on face, had descended down to abdomen. His back and upper thighs, C/O subjective fevers, primary symptom is itching. ER on the 8th, was given steroids, prescribed prednisone pills and they did not seem to have worked. Pt admitted on the 9th. Admission for observation and medication trial with high dose IV steroids, Tamiflu and Acyclovia. Pt discharges on the 12th.  12/20/05 Review of d/c summary indicates d/c diagnosis was chicken pox.
Patient received vaccine at 12:30.  Symptoms began at 14:00.  She noticed a faint pink rash on both arms and feels itchy all over.  Her tongue feels numb, but not swollen.  Her voice is hoarse.  Her heart was racing initially, but that resolved quickly.  She also felt short of breath for a few minutes, but that also resolved prior to her seeking medical care.    She has numerous medication allergies and states this feels similar to a reaction she has when she is allergic to a medication.
Bad achiness; Night sweats; Chills; Joint pain/Joint achiness; Muscle achiness; Fever; Abrupt fatigue feeling; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Bad achiness), NIGHT SWEATS (Night sweats), CHILLS (Chills), ARTHRALGIA (Joint pain/Joint achiness) and MYALGIA (Muscle achiness) in an elderly female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer (Reactions to the Pfizer vaccine mainly fatigue and a slight chill.) and Pfizer (Reactions to the Pfizer vaccine mainly fatigue and a slight chill.). Past adverse reactions to the above products included Chills with Pfizer; and Fatigue with Pfizer.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Bad achiness), NIGHT SWEATS (Night sweats), ARTHRALGIA (Joint pain/Joint achiness), MYALGIA (Muscle achiness) and PYREXIA (Fever). an unknown date, the patient experienced CHILLS (Chills) and FATIGUE (Abrupt fatigue feeling). At the time of the report, PAIN (Bad achiness), NIGHT SWEATS (Night sweats), CHILLS (Chills), ARTHRALGIA (Joint pain/Joint achiness), MYALGIA (Muscle achiness), PYREXIA (Fever) and FATIGUE (Abrupt fatigue feeling) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Patient reported that she had reactions to the Pfizer vaccine, mainly fatigue and a slight chill. 24 hours after Moderna XBB she had an abrupt fatigue feeling, chills, did not had a fever but had really bad achiness, fever, and joint pain. She had muscle achiness and joint achiness. Two nights after the vaccine she had night sweats. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Oct-2023: Live Follow-up received and had no new information.
Nauseous; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Really tired) and NAUSEA (Nauseous) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Medical history is not reported.  Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced FATIGUE (Really tired). On 28-Apr-2021, the patient experienced NAUSEA (Nauseous). On 28-Apr-2021, FATIGUE (Really tired) and NAUSEA (Nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product used by the patient includes MULTIVITAMIN for an unknown indication. No Treatment medication were reported.   This case was linked to MOD-2021-248381 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-Jul-2021 and contains no new information. On 09-Aug-2021: Follow-up received on 09-AUG-2021 included no new information.
Sore arm right away Then 8 hours after  Fever   Chills  Joint pain all over  Weakness  Patient took Tylenol and Motrin  for fever and joint pain
Itchy Sensation - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling - Near Injection Site) and INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swelling - Near Injection Site) and INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site). At the time of the report, INJECTION SITE SWELLING (Swelling - Near Injection Site) and INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications are reported. No treatment medication has been provided.
C/O ITCHING AT SITE 11/13/2009. KNOT AT SITE 11/14/2009. ITCHING MORE 11/14/2009. RASH STARTED 11/15/2009. WORSE 11/17/2009. STARTED BENADRYL. RED UNDER ARMS, ITCHING. RASH ON CHEST, ABDOMEN, AND ARMS. NO FEVER.
Administrated / vaccine / reconstituted with sterile water; Administrated / vaccine / reconstituted with sterile water; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 15-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 4th August 2021, the patient received Menveo. On 4th August 2021, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional information was provided as follows: The reporter was a medical assistant.  The patient received Menveo vaccine reconstituted with sterile water, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. No adverse event was reported. No lot number and expiration date were provided. The reporter consented to follow up.
SIDE EFFECTS; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects was not reported. This report was non-serious. This case is a duplicate of 20230227379. This case, from the same reporter is linked to 20220429250 and 20230227517.
Employee presents to dept. 48 hours after Tdap to report redness around injection site that is slightly raised. No pain or illness symptoms.
I was a little bit going through an allergy, but I had a little bit of reactions; Had a very bad headache I am barely getting out of it, terrible headache; There was a little issue with one of my platelets; Little liver issue, which is like a fatty issue or something like that; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in right arm on an unspecified date (at the age of 58-years-old) as dose 1, single for covid-19 immunization. Medical history included diabetes mellitus, hypertension and bad allergies in the allergy season. Concomitant medication included paracetamol (TYLENOL), diabetic medications, high blood pressure medications and allergy pills. At the time of vaccination patient was going through allergy, had a little bit of reactions not so bad to where her temperature went up or pain. Patient reported she had a very terrible headache, like a headache where her head was kind of like 'drugged it'. She had her blood test done, and she reported there was a little issue with one of her platelets which was 'clotting my blood pigments' (not clarified further). She also reported doctor and the pharmacy whoever got her lab results, told her that she had a little liver issue, which is like a fatty issue or something like that." The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Mother reports slight swelling and redness of injection site within 24 hours.  States area continued to swell to size of golf ball.  Seeks medical treatment 3rd day after injection.  Diagnosis Cellulitis due to inflammation 2 hours site of vaccine administration.  Site of injection that remains slightly red was increased right thigh.
Child received 2 chicken pox vaccines, chicken pox rash on 4/17/09
Itchy, raised red rash appeared on left hand and bilateral arms within 72 hours of vaccination. Rash persisted for several weeks. Left hand with scarring from rash. Have experienced brain fog since time of second vaccination.
Fully vaccinated, not boosted.   COVID infection breakthrough.   Inpatient admit to a general medical unit. LOT NUMBERS OF VACCINES NOT LISTED in Vaccine registry
Initial complaint was of a headache with achiness through shoulder and neck area, ibuprofen was taken at home. Later underside of arm felt like pins and needles at area, injection site unremarkable with only general soreness for a day or two. 10/11/12 wake with leg numbness and achiness that included numbness and cold feeling to toes on the left side and the feeling of just not wanting to get moving.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 12-OCT-2012 at 10:42, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
4 hours after receiving vaccine client experienced tachycardia while at rest for 5 minutes. Client was fine for 12-13 hours and then tachycardia returned in AM on 11-10-11.